Financial Counselors Inc’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-12,048
| Closed | -$1.22M | – | 79 |
|
|
2025
Q1 | $1.22M | Buy |
12,048
+4,680
| +64% | +$471K | 0.02% | 314 |
|
|
2024
Q4 | $658K | Sell |
7,368
-1,664
| -18% | -$146K | 0.01% | 380 |
|
|
2024
Q3 | $757K | Buy |
9,032
+30
| +0.3% | +$2.37K | 0.01% | 376 |
|
|
2024
Q2 | $693K | Sell |
9,002
-100
| -1% | -$7.32K | 0.01% | 361 |
|
|
2024
Q1 | $623K | Sell |
9,102
-60
| -0.7% | -$3.86K | 0.01% | 382 |
|
|
2023
Q4 | $530K | Buy |
9,162
+381
| +4% | +$20.3K | 0.01% | 395 |
|
|
2023
Q3 | $464K | Buy |
8,781
+3
| +0% | +$157 | 0.01% | 402 |
|
|
2023
Q2 | $475K | Sell |
8,778
-203
| -2% | -$10.6K | 0.01% | 362 |
|
|
2023
Q1 | $449K | Buy |
8,981
+117
| +1% | +$5.51K | 0.01% | 369 |
|
|
2022
Q4 | $410K | Sell |
8,864
-332
| -4% | -$14.4K | 0.01% | 387 |
|
|
2022
Q3 | $356K | Sell |
9,196
-39
| -0.4% | -$1.56K | 0.01% | 389 |
|
|
2022
Q2 | $344K | Sell |
9,235
-1,071
| -10% | -$43.6K | 0.01% | 406 |
|
|
2022
Q1 | $456K | Buy |
10,306
+873
| +9% | +$37.8K | 0.01% | 370 |
|
|
2021
Q4 | $401K | Sell |
9,433
-919
| -9% | -$38.6K | 0.01% | 385 |
|
|
2021
Q3 | $449K | Buy |
10,352
+39
| +0.4% | +$1.73K | 0.01% | 387 |
|
|
2021
Q2 | $441K | Sell |
10,313
-992
| -9% | -$41.7K | 0.01% | 386 |
|
|
2021
Q1 | $437K | Sell |
11,305
-275
| -2% | -$10.4K | 0.01% | 380 |
|
|
2020
Q4 | $416K | Buy |
11,580
+102
| +0.9% | +$3.68K | 0.01% | 385 |
|
|
2020
Q3 | $439K | Sell |
11,478
-5,993
| -34% | -$231K | 0.01% | 353 |
|
|
2020
Q2 | $613K | Buy |
17,471
+6,358
| +57% | +$229K | 0.02% | 344 |
|
|
2020
Q1 | $363K | Buy |
11,113
+304
| +3% | +$11.9K | 0.02% | 341 |
|
|
2019
Q4 | $489K | Sell |
10,809
-50
| -0.5% | -$2.09K | 0.02% | 352 |
|
|
2019
Q3 | $442K | Hold |
10,859
| – | – | 0.02% | 356 |
|
|
2019
Q2 | $467K | Hold |
10,859
| – | – | 0.02% | 343 |
|
|
2019
Q1 | $417K | Buy |
10,859
+3,867
| +55% | +$148K | 0.02% | 349 |
|
|
2018
Q4 | $247K | Sell |
6,992
-125
| -2% | -$4.53K | 0.01% | 397 |
|
|
2018
Q3 | $274K | Sell |
7,117
-199
| -3% | -$6.95K | 0.01% | 418 |
|
|
2018
Q2 | $239K | Sell |
7,316
-200
| -3% | -$6.03K | 0.01% | 440 |
|
|
2018
Q1 | $205K | Buy |
+7,516
| New | +$204K | 0.01% | 449 |
|
|
2017
Q4 | – | Sell |
-7,816
| Closed | -$228K | – | 484 |
|
|
2017
Q3 | $228K | Buy |
7,816
+278
| +4% | +$7.68K | 0.01% | 441 |
|
|
2017
Q2 | $209K | Buy |
+7,538
| New | +$200K | 0.01% | 456 |
|
|
2014
Q2 | – | Sell |
-10,848
| Closed | -$147K | – | 424 |
|
|
2014
Q1 | $147K | Buy |
+10,848
| New | +$142K | 0.01% | 420 |
|
Other funds holding BSX
Financial Counselors Inc's BSX Position: Q2 2025 in Review
Financial Counselors Inc sold out of Boston Scientific (BSX) in Q2 2025, closing a stake of 12,048 shares — an estimated $1.22M sold.
Financial Counselors Inc first reported a position in BSX in Q1 2014 and held it in 32 quarters. The position peaked at $1.22M in Q1 2025. 1,687 funds tracked by Wall St. Rank hold BSX as of Q2 2025.
- Financial Counselors Inc reported no remaining Boston Scientific position as of Q2 2025 after selling out during the quarter.
- Financial Counselors Inc sold 12,048 Boston Scientific shares in Q2 2025, an estimated $1.22M.
- Financial Counselors Inc first reported a position in Boston Scientific in Q1 2014 and held it in 32 quarters.
- Financial Counselors Inc's Boston Scientific position peaked at $1.22M in Q1 2025.
- 1,687 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2025.
Based on Financial Counselors Inc's 13F filing for Q2 2025, filed 1 Aug 2025.